Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells

In Vitro Cellular and Developmental Biology - Animal

Volumn 51, Issue 2, 2015, Pages 121-127

  Pogash, Thomas J ^a   El Bayoumy, Karam ^b   Amin, Shantu ^b   Gowda, Krishne ^b   de Cicco, Ricardo López ^a   Barton, Maria ^a   Su, Yanrong ^a   Russo, Irma H ^a   Himmelberger, Julie A ^c   Slifker, Michael ^a   Manni, Andrea ^b   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c DESALES UNIVERSITY   (United States)

Author keywords

DHA; Fish oil; Triple negative breast cancer

Indexed keywords

4-HYDROXY-5,7,10,13,16,19-DOCOSAHEXAENOIC ACID; 4-OXO-5,7,10,13,16,19-DOCOSAHEXAENOIC ACID; ANTINEOPLASTIC AGENT; DOCOSAHEXAENOIC ACID; UNSATURATED FATTY ACID;

BREAST NEOPLASMS; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; HUMAN; MCF-7 CELL LINE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MCF-7 CELLS; OXIDATION-REDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84925692529     PISSN: 10712690     EISSN: 1543706X     Source Type: Journal    
DOI: 10.1007/s11626-014-9822-6     Document Type: Article

References (37)

1. Anti M, Marra G, Armelao F, Bartoli GM, Ficarelli R, Percesepe A, De Vitis I, Maria G, Sofo L, Rapaccini GL et al (1992) Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 103:883–891
2. Berquin IM, Edwards IJ, Chen YQ (2008) Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269:363–377
3. Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D’Agostino R, Zhang H, Wu H, Kang JX, Chen YQ (2007) Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117:1866–1875
4. Blanckaert V, Ulmann L, Mimouni V, Antol J, Brancquart L, Chenais B (2010) Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int J Oncol 36:737–742
5. Carroll KK, Braden LM (1984) Dietary fat and mammary carcinogenesis. Nutr Cancer 6:254–259
6. Chajes V, Hulten K, Van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E (1999) Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer 83:585–590
7. Chapkin RS, McMurray DN, Lupton JR (2007) Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23:48–54
8. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC (2003) Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study. Br J Cancer 89:1686–1692
9. Holmes MD, Hunter DJ, Colditz GA, Stampfer MJ, Hankinson SE, Speizer FE, Rosner B, Willett WC (1999) Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 281:914–920
10. Huang Y, Fernandez SV, Goodwin S, Russo PA, Russo IH, Sutter TR, Russo J (2007) Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67:11147–11157
11. Itoh T, Fairall L, Amin K, Inaba Y, Szanto A, Balint BL, Nagy L, Yamamoto K, Schwabe JW (2008) Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat Struct Mol Biol 15:924–931
12. Itoh T, Murota I, Yoshikai K, Yamada S, Yamamoto K (2006) Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents. Bioorg Med Chem 14:98–108
13. Kaizer L, Boyd NF, Kriukov V, Tritchler D (1989) Fish consumption and breast cancer risk: an ecological study. Nutr Cancer 12:61–68
14. Kang KS, Wang P, Yamabe N, Fukui M, Jay T, Zhu BT (2010) Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 5:e10296
15. Kim S, Sandler DP, Galanko J, Martin C, Sandler RS (2010) Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol 171:969–979
16. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79:935–945
17. Liu YE, Pu W, Wang J, Kang JX, Shi YE (2007) Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids. FEBS J 274:3351–3362
18. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
19. Murphy RA, Mourtzakis M, Mazurak VC (2012) n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Curr Opin Clin Nutr Metab Care 15:246–251
20. Noguchi M, Minami M, Yagasaki R, Kinoshita K, Earashi M, Kitagawa H, Taniya T, Miyazaki I (1997) Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Br J Cancer 75:348–353
21. Rahman MM, Veigas JM, Williams PJ, Fernandes G (2013) DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA. Breast Cancer Res Treat 141:341–352
22. Ravacci GR, Brentani MM, Tortelli T Jr, Torrinhas RS, Saldanha T, Torres EA, Waitzberg DL (2013) Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression. J Nutr Biochem 24:505–515
23. Rovito D, Giordano C, Vizza D, Plastina P, Barone I, Casaburi I, Lanzino M, De Amicis F, Sisci D, Mauro L, Aquila S, Catalano S, Bonofiglio D, Ando S (2013) Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARgamma activation in MCF-7 breast cancer cells. J Cell Physiol 228:1314–1322
24. Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas JE, Wang R, Russo IH (2006a) The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 11:151–172
25. Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH (2006b) 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20:1622–1634
26. Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH (2003) Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87:1–25
27. Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, Dennison RJ, Connor KM, Aderman CM, Liclican E, Carughi A, Perelman D, Kanaoka Y, Sangiovanni JP, Gronert K, Smith LE (2011) 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of omega-3 polyunsaturated fatty acids. Sci Transl Med 3:69ra12
28. Schley PD, Brindley DN, Field CJ (2007) (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137:548–553
29. Signori C, DuBrock C, Richie JP, Prokopczyk B, Demers LM, Hamilton C, Hartman TJ, Liao J, El-Bayoumy K, Manni A (2012) Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial. Eur J Clin Nutr 66:878–884
30. Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, Hartman TJ, Manni A (2011) Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res 71:6091–6096
31. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075–6086
32. Stripp C, Overvad K, Christensen J, Thomsen BL, Olsen A, Moller S, Tjonneland A (2003) Fish intake is positively associated with breast cancer incidence rate. J Nutr 133:3664–3669
33. Sun H, Berquin IM, Owens RT, O’Flaherty JT, Edwards IJ (2008) Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res 68:2912–2919
34. Vatten LJ, Solvoll K, Loken EB (1990) Frequency of meat and fish intake and risk of breast cancer in a prospective study of 14,500 Norwegian women. Int J Cancer 46:12–15
35. Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK (2010) Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr 91:1185–1194
36. Yuri T, Danbara N, Tsujita-Kyutoku M, Fukunaga K, Takada H, Inoue Y, Hada T, Tsubura A (2003) Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutr Cancer 45:211–217
37. Zhang H, Zhou L, Shi W, Song N, Yu K, Gu Y (2012) A mechanism underlying the effects of polyunsaturated fatty acids on breast cancer. Int J Mol Med 30:487–494